{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:50:11Z","timestamp":1782201011240,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.7759\/cureus.111336","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:29:04Z","timestamp":1782199744000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hypophosphatemia and Renal Phosphate Wasting Presenting as Atraumatic Bilateral Hip Pain: Suspected Hypophosphatemic Osteomalacia"],"prefix":"10.7759","author":[{"given":"Adonai James","family":"Chery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta Ur Rehman","family":"Ilham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano P","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tissue Int. 2021, 108:128-42. 10.1007\/s00223-020-00691-6","journal-title":"Calcif Tissue Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa151","article-title":"X-linked hypophosphatemia: a new era in management","volume":"4","author":"Dahir K","year":"2020","unstructured":"Dahir K, Roberts MS, Krolczyk S, Simmons JH. X-linked hypophosphatemia: a new era in management. J Endocr Soc. 2020, 4:bvaa151. 10.1210\/jendso\/bvaa151","journal-title":"J Endocr Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab099","article-title":"Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience","volume":"5","author":"Dahir K","year":"2021","unstructured":"Dahir K, Zanchetta MB, Stanciu I, et al.. Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience. J Endocr Soc. 2021, 5:bvab099. 10.1210\/jendso\/bvab099","journal-title":"J Endocr Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng J","year":"2017","unstructured":"Feng J, Jiang Y, Wang O, et al.. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017, 64:675-83. 10.1507\/endocrj.EJ16-0587","journal-title":"Endocr J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4702","article-title":"Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia","volume":"37","author":"Hartley IR","year":"2022","unstructured":"Hartley IR, Gafni RI, Roszko KL, et al.. Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia. J Bone Miner Res. 2022, 37:2174-85. 10.1002\/jbmr.4702","journal-title":"J Bone Miner Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-025-01433-2","article-title":"Real-world effectiveness of burosumab in adults with X-linked hypophosphataemia (XLH) in the UK","volume":"116","author":"Bubbear J","year":"2025","unstructured":"Bubbear J, Lachmann R, Murphy E, et al.. Real-world effectiveness of burosumab in adults with X-linked hypophosphataemia (XLH) in the UK. Calcif Tissue Int. 2025, 116:122. 10.1007\/s00223-025-01433-2","journal-title":"Calcif Tissue Int"},{"key":"ref7","unstructured":"National Institute for Health and Care Excellence. burosumab for treating X-linked hypophosphataemia in adults. NICE Technology Appraisal Guidance TA993. (2024). https:\/\/www.nice.org.uk\/guidance\/ta993."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf170","article-title":"X-linked hypophosphatemia management in adults: an international working group clinical practice guideline","volume":"110","author":"Khan AA","year":"2025","unstructured":"Khan AA, Ali DS, Appelman-Dijkstra NM, et al.. X-linked hypophosphatemia management in adults: an international working group clinical practice guideline. J Clin Endocrinol Metab. 2025, 110:2353-70. 10.1210\/clinem\/dgaf170","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2013.12.001","article-title":"Iron and fibroblast growth factor 23 in X-linked hypophosphatemia","volume":"60","author":"Imel EA","year":"2014","unstructured":"Imel EA, Gray AK, Padgett LR, Econs MJ. Iron and fibroblast growth factor 23 in X-linked hypophosphatemia. Bone. 2014, 60:87-92. 10.1016\/j.bone.2013.12.001","journal-title":"Bone"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm-24-35","article-title":"Investigative algorithms for disorders causing hypophosphataemia and hyperphosphataemia: a narrative review","volume":"9","author":"Flowers KC","year":"2024","unstructured":"Flowers KC, Shipman KE, Shipman AR, Gittoes NJL. Investigative algorithms for disorders causing hypophosphataemia and hyperphosphataemia: a narrative review. J Lab Precis Med. 2024, 9:33. 10.21037\/jlpm-24-35","journal-title":"J Lab Precis Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-024-01317-x","article-title":"Treatment advances in tumor-induced osteomalacia","volume":"116","author":"Hartley IR","year":"2025","unstructured":"Hartley IR, Roszko KL. Treatment advances in tumor-induced osteomalacia. Calcif Tissue Int. 2025, 116:24. 10.1007\/s00223-024-01317-x","journal-title":"Calcif Tissue Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101772","article-title":"Tumor-induced osteomalacia: a systematic literature review","volume":"21","author":"\u00c1lvarez-Rivas N","year":"2024","unstructured":"\u00c1lvarez-Rivas N, Lugo-Rodr\u00edguez G, Maneiro JR, et al.. Tumor-induced osteomalacia: a systematic literature review. Bone Rep. 2024, 21:101772. 10.1016\/j.bonr.2024.101772","journal-title":"Bone Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496310-severe-hypophosphatemia-and-renal-phosphate-wasting-presenting-as-atraumatic-bilateral-hip-pain-suspected-hypophosphatemic-osteomalacia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:29:10Z","timestamp":1782199750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496310-severe-hypophosphatemia-and-renal-phosphate-wasting-presenting-as-atraumatic-bilateral-hip-pain-suspected-hypophosphatemic-osteomalacia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.111336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}